Europe Next Generation Sequencing Market in China : Share, Analysis, Market Forecast And Growth Research Report
The Europe next generation sequencing
market is expected to reach US$ 7,685.4 Mn in 2025 from US$ 1,633.4 Mn in 2017.
The market is estimated to grow with a CAGR of 21.4% from 2018-2025.
The growth of the next generation sequencing market is primarily
attributed to the technological advancements in sequencing and an extensive use
of genomics for medical applications. However, nonexistence of skilled
professionals and high risks associated with genetic data. On the other hand,
an extensive use of genomics for medical applications is likely to have a
positive impact on the growth of the Europe next generation sequencing market
in the coming years.
The genomics is comprised of various technologies such next
generation sequencing (NGS), genome editing, gene synthesis and more. These
technologies have been utilized for achieving various discoveries for the
betterment of the health conditions across the living organisms. The next
generation sequencing is widely used in the field of the medical to understand
the genetic composition of the patients. The use of NGS has been utilized for
the alteration of plants and animals for the desired physical and genetic
changes. The technology is used to produce biomarkers. The biomarkers are
widely used in clinical research and clinical practice. NGS is among the
important developments in genomic technologies, the technology is used for the
discovery of oncogenic biomarker and diagnostics. NGS enables in discovery of
biomarker and identifying the genetic diseases. In addition, the NGS is used
for the developing precision medicine for individual’s genomic information to
offer targeted treatment to the individual. NGS have capability of sequencing
large sections of a person's genome in very short period of time and can also
aid in formulation of precision medicine. Next generation sequencing technology
is among the major driver of precision medicine and has improved its accuracy,
speed, and cost. Developments in whole genome sequencing has enabled the
identification of genes required in the large number of diseases, and
biomarkers that indicate disease severity to treatment are gradually being
characterized. Therefore, the use of the NGS for the discovery of biomarker
have benefited for the early diagnosis and differentiating in disease types.
Likewise, precision medicine enables in treatment of the diseases NGS plays
significant role for both the application by creating an array of opportunities
in future.
Get Sample PDF Of Europe
Next Generation Sequencing Market @
In 2017, the consumables segment held a largest market share of
64.0% of the next generation sequencing market, by product. The segment is
growing due to the consumables offered by various companies are widely accepted
by the consumers and it provides accuracy and precision in the preparation of
the NGS. Furthermore, the similar segment is anticipated to witness the fastest
growth rate during the forecast period, 2018 to 2025.
In 2017, the resequencing segment held a largest market share of
66.0% of the next generation sequencing market, by technology. This segment is
also expected to dominate the market in 2025 as the rising funding by various
government bodies and usage of NGS in the resequencing and targeted sequencing.
Furthermore, the genome sequencing segment is anticipated to witness the
fastest growth rate during the forecast period, 2018 to 2025.
Diagnostics segment is anticipated to grow at a CAGR of 22.0%
during the forecast period owing to the growth of the technological
advancements such as sequencing machines in the developed and developing
regions. Moreover, the similar segment held the largest market share of 34.0%
for the application segment in the next generation sequencing market and is
likely to dominate the market in coming forecast period.
Ask For Discount @
In 2017, the academic & research institutes segment held a
largest market share of 45.2% of the next generation sequencing market, by end
user. This segment is also expected to dominate the market in 2025. Moreover,
the similar segment is anticipated to witness the fastest growth rate of 21.9%
during the forecast period, 2017 to 2025. This higher growth rate of the
segment owing to the providing the references for further researches are likely
to propel the growth of the research centers segment in the coming future.
Some of the major primary and secondary sources for next
generation sequencing included in the report are, Non-Invasive Prenatal Testing
(NIPT), Food and Drug Administration (FDA), Developing an European - American
NGS Network (DEANN), Foreign Direct Investment (FDI) and among others.
About Us :
Intelligence Market Research & Consulting, LLP (IMRC) is a
global provider of research reports, business intelligence & consulting
services. We know and understand the importance of market research data for
your institution. Therefore, we have teamed up with the leading research
institutes and strategy specialists to bring to you the latest, niche and most
relevant statistical research.
At IMRC, we have one of the most exhaustive, highly reliable
database of market research reports sourced from publishers and authors after a
thorough quality check and screening of the market study and credentials. We
have a team of key market experts who evaluate the market size, growth
prospects, end-use, applications, value & supply chain and top vendors in
the industry to help the clients to take most accurate and logical business
decisions without any vague assumptions.
Contact
Us:
699, Butler St. Suite 1007
Saugatuck, MI - 49453, United States.
Phone : +1 209
691 5657
Comments
Post a Comment